Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme

Immunogenic cell death (ICD), a unique form of cancer cell death, has therapeutic potential in anti-tumour immunotherapy. The aim of this study is to explore the predictive potential of ICD in the prognosis and immunotherapy outcomes of glioblastoma multiforme (GBM). RNA sequencing data and clinical...

詳細記述

書誌詳細

出版年:	Open Medicine
主要な著者:	Liu Zhiye, Li Wei, You Guoliang, Hu Zhihong, Liu Yuji, Zheng Niandong
フォーマット:	論文
言語:	英語
出版事項:	De Gruyter 2023-06-01
主題:	glioblastoma multiforme immunogenic cell death prognosis immunotherapy tumour mutation burden
オンライン･アクセス:	https://doi.org/10.1515/med-2023-0716